DALLAS – Discussion of the recently released – and significantly expanded – guidelines for treating cholesterol at the American Heart Association annual meeting suggest that the lower costs associated with statin therapy helped pave the way for aggressive treatment recommendations.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?